Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Prognosis Value of Protein S100Beta and Copeptine in Seizure in the Emergency Department

NCT01774500 is registered in ClinicalTrials.gov with Bistro Study Group as lead sponsor.

NCT NCT01774500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01774500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Prognosis Value of Protein S100Beta and Copeptine in Seizure in the Emergency Department
Lead sponsor
Bistro Study Group
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
March 31, 2014
Enrollment
300 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

copeptin, s-100b protein, seizures